Phosphodiesterase-5 Inhibitors and Dementia Risk: Confounding by Indication in Real-World Studies
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Alzheimer's Disease"
DOI: 10.3233/jad-240520
Abstract: Pharmacoepidemiologic studies using routinely collected data allow researchers to propose drugs for repurposing trials for dementia prevention or treatment. A recent cohort study reported a 54% lower dementia risk among users of sildenafil compared to… read more here.
Keywords: risk; risk confounding; dementia risk; confounding indication ... See more keywords